{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:43:17Z","timestamp":1783608197053,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Behav. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Many psychiatric illnesses have been linked to the gut microbiome, with supplements such as probiotics showing some efficacy in alleviating the symptoms of some psychiatric illnesses. The aim of this review is to evaluate the current literature investigating the effects of adjuvant probiotic or synbiotic administration in combination with first-line treatments for psychiatric illnesses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A systematic search of four databases was conducted using key terms related to treatments for psychiatric illnesses, the gut microbiome, and probiotics. All results were then evaluated based on specific eligibility criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight studies met eligibility criteria and were analyzed for reported changes in outcome measures used to assess the symptoms of psychiatric illness and the tolerability of treatment. All Major Depressive Disorder (MDD) (<jats:italic>n<\/jats:italic> = 5) and Generalized Anxiety Disorder (GAD) (<jats:italic>n<\/jats:italic> = 1) studies found adjuvant probiotic or synbiotic treatment to be more efficacious in improving the symptoms of psychiatric illness than the first-line treatment alone or with placebo. The schizophrenia studies (<jats:italic>n<\/jats:italic> = 2) found adjuvant probiotic treatment to have no significant difference in clinical outcomes, but it was found to improve the tolerability of first-line antipsychotics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and conclusion<\/jats:title><jats:p>The findings of the studies included in this review suggest the use of adjuvant probiotic treatment with selective serotonin reuptake inhibitors (SSRIs) for MDD and GAD to be superior to SSRI treatment alone. Probiotic adjuvant treatment with antipsychotics could be beneficial for improving the tolerability of the antipsychotics, but these findings do not suggest that adjuvant probiotic treatment would result in improved clinical outcomes for symptoms of schizophrenia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnbeh.2023.1111349","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T05:52:06Z","timestamp":1675921926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Systematic review of probiotics as an adjuvant treatment for psychiatric disorders"],"prefix":"10.3389","volume":"17","author":[{"given":"Evan","family":"Forth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Buehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Sgarbossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Chinna Meyyappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74934-9","article-title":"Unravelling the antimicrobial action of antidepressants on gut commensal microbes.","volume":"10","author":"Ait Chait","year":"2020","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","year":"2013","journal-title":"Diagnostic and statistical manual of mental disorders: DSM-5.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.15275\/rusomj.2021.0109","article-title":"The role of probiotics in combination therapy of depressive disorders.","volume":"10","author":"Arifdjanova","year":"2021","journal-title":"Russ. Open Med. J."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1199","article-title":"Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta-analysis.","volume":"342","author":"Baldwin","year":"2011","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1037\/t00742-000","author":"Beck","year":"1996","journal-title":"Manual for the beck depression inventory-II."},{"key":"B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","article-title":"The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice.","volume":"141","author":"Bercik","year":"2011","journal-title":"Gastroenterology"},{"key":"B7","first-page":"70","article-title":"The microbiota: An exercise immunology perspective.","volume":"21","author":"Bermon","year":"2015","journal-title":"Exerc. Immunol. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E358","DOI":"10.1503\/jpn.200159","article-title":"Blood microbiota and metabolomic signature of major depression before and after antidepressant treatment: A prospective case\u2013control study.","volume":"46","author":"Ciocan","year":"2021","journal-title":"J. Psychiatry Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress.","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.bjp.0705762","article-title":"Role of serotonin in the pathophysiology of the irritable bowel syndrome.","volume":"141","author":"Crowell","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis.","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00213-019-5185-8","article-title":"Psychotropics and the microbiome: A chamber of secrets.","volume":"236","author":"Cussotto","year":"2019","journal-title":"Psychopharmacology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice.","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"B14","first-page":"679","article-title":"The SCL-90-R, brief symptom inventory, and matching clinical rating scales","author":"Derogatis","year":"1999","journal-title":"The use of psychological testing for treatment planning and outcomes assessment"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.13m01579","article-title":"Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: A randomized, placebo-controlled trial.","volume":"16","author":"Dickerson","year":"2014","journal-title":"Prim. Care Companion CNS Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/1028415X.2019.1598669","article-title":"Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: A double blind, randomized, placebo-controlled trial.","volume":"24","author":"Eskandarzadeh","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1017\/S0033291717003336","article-title":"Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: Results from the WHO world mental health (WMH) surveys.","volume":"48","author":"Evans-Lacko","year":"2018","journal-title":"Psychol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.1890","article-title":"Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort.","volume":"37","author":"Flowers","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00160","article-title":"The role of inflammation in the treatment of schizophrenia.","volume":"11","author":"Fond","year":"2020","journal-title":"Front. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8090311","article-title":"Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants.","volume":"8","author":"Fontana","year":"2020","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","article-title":"The gut microbiome and the brain.","volume":"17","author":"Galland","year":"2014","journal-title":"J. Med. Food"},{"key":"B22","first-page":"9","article-title":"American psychiatric association practice guidelines for the treatment of patients with major depressive disorder.","volume":"167","author":"Gelenberg","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5812\/archneurosci.60507","article-title":"The effect of synbiotic as an adjuvant therapy to fluoxetine in moderate depression: A randomized multicenter trial.","volume":"5","author":"Ghorbani","year":"2018","journal-title":"Arch. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmet.2016.02.005","article-title":"A healthy gastrointestinal microbiome is dependent on dietary diversity.","volume":"5","author":"Heiman","year":"2016","journal-title":"Mol. Metab."},{"key":"B27","author":"Hirsch","year":"2017","journal-title":"Selective serotonin reuptake inhibitors: Pharmacology, administration, and side effects"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051728","article-title":"Exploring the role and potential of probiotics in the field of mental health: Major depressive disorder.","volume":"13","author":"Johnson","year":"2021","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut.","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"B31","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.clnu.2018.04.010","article-title":"Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial.","volume":"38","author":"Kazemi","year":"2019","journal-title":"Clin. Nutr."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02777-6","article-title":"Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials.","volume":"9","author":"Korbee","year":"2018","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4093\/dmj.2015.39.4.291","article-title":"Probiotics as complementary treatment for metabolic disorders.","volume":"39","author":"Le Barz","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000319504","article-title":"The concept of depression as a dysfunction of the immune system","author":"Leonard","year":"2010","journal-title":"Depression: From psychopathology to pharmacotherapy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome.","volume":"32","author":"Li","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103908","article-title":"Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS.","volume":"77","author":"Liu","year":"2022","journal-title":"EBioMedicine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0466-x","article-title":"Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior.","volume":"9","author":"Luki\u0107","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria.","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1590\/S1517-83822010000300014","article-title":"An Investigation on in vitro and in vivo antimicrobial properties of the antidepressant: Amitriptyline hydrochloride.","volume":"41","author":"Mandal","year":"2010","journal-title":"Braz. J. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158498","article-title":"Early-life events, including mode of delivery and type of feeding, siblings and gender, shape the developing gut microbiota.","volume":"11","author":"Martin","year":"2016","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1177\/0004867419877954","article-title":"A review of the antimicrobial side of antidepressants and its putative implications on the gut microbiome.","volume":"53","author":"McGovern","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02654-5","article-title":"Effect of fecal microbiota transplant on symptoms of psychiatric disorders: A systematic review.","volume":"20","author":"Meyyappan","year":"2020","journal-title":"BMC Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WNF.0000000000000299","article-title":"Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: A prospective open-label trial.","volume":"41","author":"Miyaoka","year":"2018","journal-title":"Clin. Neuropharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","article-title":"The gut microbiota\u2013brain axis in behaviour and brain disorders.","volume":"19","author":"Morais","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115225","article-title":"The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.","volume":"9","author":"Morgan","year":"2014","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0924-8579(99)00154-5","article-title":"Antimicrobial activity of psychotropic drugs: Selective serotonin reuptake inhibitors.","volume":"14","author":"Munoz-Bellido","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2982.2010.01620.x","article-title":"Reduced anxiety-like behavior and central neurochemical change in germ-free mice.","volume":"23","author":"Neufeld","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","article-title":"Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis.","volume":"78","author":"Nikolova","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/916198","article-title":"Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review.","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr. Res. Treatment"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0708-5","article-title":"Age-related changes in gut microbiota composition from newborn to centenarian: A cross-sectional study.","volume":"16","author":"Odamaki","year":"2016","journal-title":"BMC Microbiol."},{"key":"B52","first-page":"638","article-title":"Schizophrenia: Overview and treatment options.","volume":"39","author":"Patel","year":"2014","journal-title":"Pharm. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","article-title":"Probiotic Lactobacillus plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study.","volume":"100","author":"Rudzki","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5455\/msm.2021.33.105-108","article-title":"Major depressive disorder and difference between genders.","volume":"33","author":"Sabic","year":"2021","journal-title":"Mater. Sociomed."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.4088\/JCP.v69n1011","article-title":"Gender differences in generalized anxiety disorder: Results from the national epidemiologic survey on alcohol and related conditions (NESARC).","volume":"69","author":"Vesga-L\u00f3pez","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00213-021-05866-z","article-title":"Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis.","volume":"238","author":"Yang","year":"2021","journal-title":"Psychopharmacology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.3748\/wjg.v16.i27.3394","article-title":"Effects of four Bifidobacteria on obesity in high-fat diet induced rats.","volume":"16","author":"Yin","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01531-3","article-title":"Gut microbial biomarkers for the treatment response in first-episode, drug-na\u00efve schizophrenia: A 24-week follow-up study.","volume":"11","author":"Yuan","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/s41380-019-0475-4","article-title":"Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice.","volume":"25","author":"Zhu","year":"2020","journal-title":"Mol. Psychiatry"}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnbeh.2023.1111349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T05:52:14Z","timestamp":1675921934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnbeh.2023.1111349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":59,"alternative-id":["10.3389\/fnbeh.2023.1111349"],"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2023.1111349","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"article-number":"1111349"}}